Back to Ovarian Cancer
NCT06972693
NCT06972693
Who may be able to join
Who might be able to join this trial:
- You are 18 years of age or older
- You have agreed to take part and signed a consent form
- You have been diagnosed with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, confirmed through a tissue sample examination
- Any stage of the cancer is accepted
- Any type (cell/tissue variety) of the cancer is accepted
- A tissue sample from a previous surgery or biopsy is available (either preserved in a standard laboratory way or frozen, with no time limit on when it was taken)
Who may not be able to join:
- You are unwilling or unable to receive genetic counseling
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 4: approximately Approved of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Active, Not Recruiting
Phase
Phase 4
Sponsor
European Institute of Oncology
Registry
clinicaltrials_gov
Start date
12 June 2018
Est. completion
30 December 2025
Where this trial is recruiting
🇮🇹 Italy
Primary endpoints
Prevalence of clinically relevant mutations in ovarian cancer riskassociated genes; Percentage of informative specimens; Genetic test turnaround time
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.